Harvard Heart Letter

Lessons from the blood pressure drug recall

Here’s what you need to know about the discovery of contaminants in a popular class of heart medications. Last summer, a number of prescription medications containing the generic drug valsartan were recalled by manufacturers after investigators found trace amounts of possible cancer-causing impurities in some of the products. Over the following months, additional lots of valsartan, as well as batches of two similar drugs, losartan and irbesartan, were also pulled from pharmacy…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In